Patents-Review.com
ClassID:

110663 ⎘

C12N2760/12022 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Bunyaviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Recent Application in this class:
#1
20250041398
2025-02-06

A THERAPEUTIC AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS

 #2
20240374707
2024-11-14

EXPRESSION SYSTEM AND NUCLEIC ACID-BASED PHARMACEUTICAL COMPOSITION COMPRISING SAME

 #3
20210290753
2021-09-23

CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS IMMUNOGENIC COMPOSITIONS

 #4
20210220463
2021-07-22

VECTORS FOR DNA VACCINATION

 #5
20200147202
2020-05-14

LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE

 #6
20190117762
2019-04-25

Live attenuated virus vaccines for La Crosse virus and other bunyaviridae

 #7
20180104326
2018-04-19

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

 #8
20160367657
2016-12-22

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

 #9
20160250317
2016-09-01

Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof

 #10
20160002608
2016-01-07

Methods to produce bunyavirus replicon particles

 #11
20150266929
2015-09-24

Virus-like particles, methods of preparation, and immunogenic compositions

 #12
20140023679
2014-01-23

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

 #13
20130323277
2013-12-05

Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof

 #14
20130323210
2013-12-05

Infectious Schmallenberg virus from cloned CDNAS and uses thereof

 #15
20130236493
2013-09-12

Methods to produce bunyavirus replicon particles

 #16
20130071429
2013-03-21

BUNYAVIRUS VACCINE

 #17
20110200630
2011-08-18

Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

 #18
20110150911
2011-06-23

Methods and reagents for treating, preventing and diagnosing bunyavirus infection

 #19
20110033498
2011-02-10

Methods of preventing and treating viral infections by inhibiting the deISGylation activity of OTU domain-containing viral proteins

 #20
20090031447
2009-01-29

Use of a tospoviral nucleid acid molecule for broad-spectrum transgenic resistance against different tospoviruses

 #21
20080300210
2008-12-04

Method of Controlling Insects and Virus Transmission

 #22
20080188640
2008-08-07

Immunodeficiency recombinant poxvirus

 #23
20080026004
2008-01-31

Membrane virus host range mutations and their uses as vaccine substrates

 #24
20060216702
2006-09-28

Virus-like particles, methods of preparation, and immunogenic compositions